STARTUP PROFILE

The Biological Computing Co

COUNTRY
USA
FOUNDED
2022
CATEGORY
Tools and Infrastructure
Building an organic computing platform that integrates living human neurons with modern AI architectures to improve model efficiency and discover novel computational algorithms.
Visit website →
Neurofounders Insights
$   Funding   -
Seed
MODALITY
MEA
FORM FACTOR
Other
INTERFACE DEPTH
Ex vivo
INDICATION
Research
TARGET USER
Mixed
REGULATORY STAGE
Research only
The Biological Computing Company is one of the most commercially ambitious wetware companies, targeting the AI infrastructure market rather than clinical applications, with $25M seed funding suggesting strong investor conviction in biological computing as a complement to silicon. Its Algorithm Discovery platform is a differentiating concept, though its 10-to-20-year roadmap candidly reflects how early the underlying biology-AI integration remains.
Mentioned in Market Notes
MOST RECENT COVERAGE
#
6
BCI Goes Commercial
21 July – 4 August 2026

The Biological Computing Co. released a playable proof-of-concept for its neurally-optimised AI software, applying its technology to an interactive video model trained on Minecraft gameplay. The San Francisco company studies how living neurons process information, then translates those principles into software that makes AI models more efficient. Real neurons are used during the optimisation process, but the resulting model runs on conventional GPUs, so users need no biological hardware. TBC plans to launch its first commercial neurally-optimised text-to-video model later this year.

Articles featuring
The Biological Computing Co